Results 161 to 170 of about 30,985 (226)

A phase II study of DFP-14323, a non-specific immunomodulator, in combination with low-dose afatinib as first-line therapy for common <i>EGFR</i> mutation-positive NSCLC. [PDF]

Ther Adv Med Oncol
Yoshioka H, Mori M, Katakami N, Yokoyama T, Kaneda H, Matsumoto H, Tamiya M, Yamamoto K, Huang CL.   +8 more
europepmc   +1 more source

Clinical Outcomes, Treatment Patterns, and Molecular Heterogeneity of TFE3-Rearranged Renal Cell Carcinoma: A Multicenter Real-World Study. [PDF]

Cancer Med
Zhu S, Zhou S, Tian X, Wang J, Wang Z, Jiang J, Liu Q, Gou X, Zhou X, Gu J, Yang J, Chen J, Chen S, Wang W, Anwaier A, Chang K, Qu Y, Brugarolas J, Xu W, Zhang H, Ye D.   +20 more
europepmc   +1 more source

Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumors. [PDF]

BMC Cancer
Soyfer EM, Lee BJ, Qavi AJ, Masri S, Fleischman AG, Dayyani F.   +5 more
europepmc   +1 more source

Ostium pathologies in DCR: Ophthalmologist’s perspective

Indian Journal of Ophthalmology. Case Reports
Charudutt Kalamkar, Rohit Rao, Jagadish Kumar   +2 more
doaj   +1 more source

The Association and Predictive Value of Nutritional and Inflammatory Biomarkers in Advanced Non-Small Cell Lung Cancer Response to Immune Checkpoint Inhibitors. [PDF]

Cancers (Basel)
Dekker M, Suazo-Zepeda E, Hiltermann TJN, De Bock GH, Heuvelmans MA.   +4 more
europepmc   +1 more source

Predictive value of nutritional biomarkers for immune checkpoint inhibitor efficacy in patients with non-small cell lung cancer. [PDF]

Front Nutr
Zhang W, Liu X.
europepmc   +1 more source

To compare the efficacy of endoscopic dacryocystorhinostomy and external dacryocystorhinostomy in the treatment of chronic dacryocystitis based on propensity score matching. [PDF]

BMC Ophthalmol
Hong J, Tang F, Ren D, Yu X, Xia J, He F.   +5 more
europepmc   +1 more source

Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung Cancer. [PDF]

Adv Ther
Dirnberger F, Patel S, Boyne DJ, Lan Z, Uyei J, Wang J, Cho S, DeCosta L, Bridges IM, Tapan U.   +9 more
europepmc   +1 more source

Post-Treatment NLR and SII Associations with Response and Progression-Free Survival After Neoadjuvant Disitamab Vedotin Plus PD-1 Blockade in Muscle-Invasive Bladder Cancer: A Real-World Cohort Study. [PDF]

Diagnostics (Basel)
Huang Y, Ji Y, Yang X, Zhao Q, Cao Y, Ma J, You R, Li Y, Yang Y, Du P, Wang S.   +10 more
europepmc   +1 more source

Damage control resuscitation in resource-diverse settings: a survey-based comparison of trauma care practices worldwide. [PDF]

Acta Cir Bras
Pacheco LS, Possiedi RD, Scalea TM, Ribeiro Junior MAF.   +3 more
europepmc   +1 more source